# Evaluation of Diabetes Control and Effect on Transmission and Development of Tuberculosis

> **NCT03498534** · PHASE4 · WITHDRAWN · sponsor: **Instituto Nacional de Salud Publica, Mexico**

## Conditions studied

- Latent Tuberculosis
- Diabetes Mellitus

## Interventions

- **DRUG:** Isoniazid 300Mg Tab
- **DRUG:** Isoniazid 300 MG
- **DRUG:** Isoniazid 300 MG

## Key facts

- **NCT ID:** NCT03498534
- **Lead sponsor:** Instituto Nacional de Salud Publica, Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-09
- **Primary completion:** 2012-12
- **Final completion:** 2013-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to administrative procedures
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03498534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03498534, "Evaluation of Diabetes Control and Effect on Transmission and Development of Tuberculosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03498534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*